Britannia Life Sciences Inc. (CSE: BLAB)
Canada
· Delayed Price · Currency is CAD 0.0800
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST
Britannia Life Sciences Cash Flow Statement
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 29, 2024 | Mar '24 Mar 30, 2024 | Mar '23 Mar 30, 2023 | Mar '22 Mar 30, 2022 | Mar '21 Mar 30, 2021 | Mar '20 Mar 30, 2020 |
| Net Income | -7.31 | -4.77 | 5.08 | -15.46 | -0.16 | -0.63 |
| Depreciation & Amortization | 0.2 | 0.23 | 0.16 | 0.19 | 0.04 | - |
| Other Amortization | 0.16 | 0.1 | 0.07 | 0 | 0 | - |
| Loss (Gain) From Sale of Assets | -0.54 | -0.47 | -1.39 | - | - | - |
| Loss (Gain) on Equity Investments | 1.79 | 0.96 | 0.02 | 0 | - | - |
| Stock-Based Compensation | 0.04 | 0.23 | 1.05 | 1.11 | - | - |
| Other Operating Activities | 6.15 | 4.93 | -2.57 | 16.5 | 0.22 | -0.01 |
| Change in Accounts Receivable | 0.04 | 0.56 | 0.2 | -0.1 | -0.24 | -0.02 |
| Change in Inventory | 0 | 0.07 | - | - | - | - |
| Change in Accounts Payable | 0.3 | 0.24 | -0.65 | 0.62 | -0.45 | 0.17 |
| Change in Other Net Operating Assets | 0.17 | 0.01 | 0.04 | -0.05 | - | - |
| Operating Cash Flow | 1 | 2.09 | 2.01 | 2.8 | -0.59 | -0.5 |
| Operating Cash Flow Growth | -56.71% | 4.15% | -28.26% | - | - | - |
| Capital Expenditures | -0.02 | -0.13 | -0.06 | -0.09 | 0.04 | - |
| Cash Acquisitions | -0.93 | -1.1 | -2.98 | 0.74 | -4.96 | - |
| Sale (Purchase) of Intangibles | -0.35 | -0.2 | -0.29 | - | - | - |
| Investing Cash Flow | -1.31 | -1.44 | -3.32 | 0.65 | -4.91 | - |
| Short-Term Debt Issued | - | 0.03 | - | 0.12 | 0.23 | - |
| Long-Term Debt Issued | - | - | 7.98 | 1.41 | 6 | - |
| Total Debt Issued | 0.8 | 0.03 | 7.98 | 1.53 | 6.22 | - |
| Short-Term Debt Repaid | - | - | -4.96 | -3.44 | - | - |
| Long-Term Debt Repaid | - | -2 | -0.07 | -0.08 | -0.02 | - |
| Total Debt Repaid | -2.17 | -2 | -5.03 | -3.52 | -0.02 | - |
| Net Debt Issued (Repaid) | -1.37 | -1.97 | 2.95 | -1.99 | 6.2 | - |
| Issuance of Common Stock | - | - | - | 0 | - | 0.66 |
| Other Financing Activities | - | - | -0.79 | -0.6 | -0 | -0.01 |
| Financing Cash Flow | -1.37 | -1.97 | 2.16 | -2.58 | 6.2 | 0.65 |
| Foreign Exchange Rate Adjustments | 0.14 | 0.05 | 0.13 | -0.07 | -0.02 | - |
| Net Cash Flow | -1.54 | -1.28 | 0.97 | 0.8 | 0.69 | 0.15 |
| Free Cash Flow | 0.98 | 1.96 | 1.95 | 2.71 | -0.54 | -0.5 |
| Free Cash Flow Growth | -54.80% | 0.19% | -27.99% | - | - | - |
| Free Cash Flow Margin | 13.44% | 25.85% | 30.50% | 37.16% | -38.15% | - |
| Free Cash Flow Per Share | 0.01 | 0.01 | 0.01 | 0.02 | -0.01 | -0.08 |
| Cash Interest Paid | - | - | 0.79 | - | - | - |
| Levered Free Cash Flow | 5.82 | 6.16 | 0.43 | 1.79 | 0.41 | - |
| Unlevered Free Cash Flow | 6.57 | 6.96 | 0.96 | 3.24 | 0.63 | - |
| Change in Net Working Capital | -5.87 | -5.94 | 0.6 | -1.02 | -0.37 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.